Product Information
MENOSTAR 14 MCG/DAY PATCH is a brand product labeled by Bayer HealthCare Pharmaceuticals Inc., priced at $38.7401 per EA under NDC 50419045504. Its NADAC has been published 450 times since Nov 28, 2013.
FDA first approved this application on Dec 22, 1994. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
14 ug/d
Manufacturer
Bayer HealthCare Pharmaceuticals Inc.NDC
50419045504
Classification
Brand
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
ESTRADIOLApproval Type
New Drug (NDA)
FDA Application
NDA020375FDA Approved
12/22/1994
TE Code
AB2
On Market Since
6/8/2004
Pharmacological Classes
Price Statistics
The NADAC for MENOSTAR 14 MCG/DAY PATCH has been published 450 times since Nov 28, 2013, and over the history we have for it it has risen 56.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $38.7401 per EA |
|---|---|
| All-time high | $39.0545 (Sep 11, 2024) |
| All-time low | $24.3225 (Jul 23, 2014) |
| 52-week high | $38.9517 |
| 52-week low | $38.7322 |
| Median price | $38.4515 |
| Average price | $34.2231 |
| Largest weekly change | +9.9% (Jan 3, 2018) |
| Weeks tracked | 450 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bayer HealthCare Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MENOSTAR 14 MCG/DAY PATCH?
The current National Average Drug Acquisition Cost (NADAC) for MENOSTAR 14 MCG/DAY PATCH, manufactured by Bayer HealthCare Pharmaceuticals Inc., is $38.7401 per EA (NDC 50419045504), effective Sep 30, 2026.
How has the price of MENOSTAR 14 MCG/DAY PATCH changed over time?
Over the history we have for it, the NADAC for MENOSTAR 14 MCG/DAY PATCH has risen 56.6%. It has been tracked across 450 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MENOSTAR 14 MCG/DAY PATCH?
Since Nov 28, 2013, the NADAC for MENOSTAR 14 MCG/DAY PATCH has ranged from a low of $24.3225 (Jul 23, 2014) to a high of $39.0545 (Sep 11, 2024), with a median of $38.4515 per EA.
Are there cheaper alternatives to MENOSTAR 14 MCG/DAY PATCH?
No other NADAC-published product currently shares the active ingredient and strength of MENOSTAR 14 MCG/DAY PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MENOSTAR 14 MCG/DAY PATCH?
MENOSTAR 14 MCG/DAY PATCH (NDC 50419045504) is labeled by Bayer HealthCare Pharmaceuticals Inc., and CMS classifies it as a brand product.